(Press-News.org) An inexpensive type 2 diabetes drug that has been around for more than 15 years works just as well and has fewer side effects than a half-dozen other, mostly newer and more expensive classes of medication used to control the chronic disease, new Johns Hopkins research suggests.
In their report, published online March 14 in the journal Annals of Internal Medicine, the Hopkins team found that metformin, an oral drug that was first approved by the U.S. Food and Drug Administration in 1995, not only controlled blood sugar, but was also less likely to cause weight gain or raise cholesterol levels.
"Metformin works for most people. It's cheaper, there's a generic form — it's tried and true," says study leader Wendy L. Bennett, M.D., M.P.H., an assistant professor in the Division of General Internal Medicine at the Johns Hopkins University School of Medicine. "Our study shows that even though there are all these newer drugs, metformin works just as well and has fewer side effects."
The study is an update of Hopkins research published in 2007 that also showed there were advantages to metformin. New classes of medication for adult-onset diabetes have been approved by the FDA since then, and Bennett and her colleagues wanted to know if the newer drugs were any better than the older crop. The research team also looked for the first time at the efficacy of two-drug combinations to treat the chronic disease, which has become increasingly common with more than one-third of diabetes patients needing multiple medications. Researchers found that while two drugs worked better than one in those patients whose blood sugar remained poorly controlled on a single medication, there were also side effects associated with adding a second medication.
"Diabetes is an enormous public health problem, and patients have difficult decisions to make about what medications they should be taking," Bennett says. "Our study provides good information comparing drugs and can be used to inform those decisions."
Bennett and her colleagues reviewed 166 previously published medical studies that examined the effectiveness and safety of diabetes drugs, as well as their impact on long-term outcomes including death, cardiovascular disease, kidney disease and nerve disease. The team had previously looked at several popular classes of oral diabetes medication — metformin (sold as Glucophage, Fortamet and others), second-generation sulfonylureas (Amaryl, Glucotrol and more), thiazolidinediones (Avandia and Actos) and meglitinides (Starlix and Prandin) — and added two new classes of drugs, dipeptidyl peptidase-4 (DPP-4) inhibitors (Januvia and Onglynza) and glucagon-like peptide-1 (GLP-1) receptor agonists (Byetta and Victoza), which are given by injection.
No drug or combination of drugs was shown to have an advantage in improving long-term outcomes, Bennett says, primarily because there weren't enough long-term studies, particularly of newer medications.
While most drugs reduced blood sugar similarly, metformin was consistently associated with fewer side effects. Though metformin is associated with increased risk of gastrointestinal side effects, Bennett, an internist, says she finds many of her patients can overcome them by starting with a low dose and taking it with meals, though patients with severe kidney disease may avoid it. The sulfonylureas and meglitinides were associated with increased risk for hypoglycemia, or dangerously low blood sugar levels. The thiazolidinediones increased risk of heart failure, weight gain and fractures. In September 2010, the FDA placed restrictions on the use of Avandia because of concerns that the drug increases the risk of heart attack.
Meanwhile, the new medications, because there are no generic options, are significantly more expensive than older ones. One hundred metformin pills cost about $35.57, or 35 cents a pill, while 30 Januvia pills (a DPP-4 inhibitor) cost $192.52, or $6.42 a pill — nearly 18 times as much.
While the drugs all reduce blood sugar levels, Bennett says more research is needed into whether they actually improve outcomes for diabetics in the long run. It remains an open question as to whether patients with type 2 diabetes who have their blood sugar controlled by medication will reduce their chances of having complications associated with the disease, including eye, kidney and nerve diseases, she says.
"Some of the drugs haven't been on the market long enough to study the long-term effects or even some of the short-term rare side effects, so we need longer studies in patients who are at highest risk for complications" she says.
###
More than 25 million Americans have type 2 diabetes, and the number of diagnoses have been steadily rising, with 1.9 million new cases diagnosed in 2010. Like many chronic illnesses, diabetes disproportionately affects older people, and its prevalence is higher among racial and ethnic minorities. The annual economic burden of diabetes is an estimated $132 billion and increasing, mostly attributable to costly complications of the disease.
The study was paid for by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality.
Along with Bennett, other Hopkins researchers involved in this work include Nisa M. Maruthur, M.D., M.H.S.; Sonal Singh, M.D., M.P.H.; Jodi B. Segal, M.D., M.P.H.; Lisa M. Wilson, Sc.M.; Spyridon S. Marinopoulos, M.D., M.B.A.; Milo A. Puhan, M.D., Ph.D.; Padmini Ranasinghe, M.D., M.P.H.; Lauren Block, M.D.; Susan Hutfless, Ph.D.; and Eric B. Bass, M.D., M.P.H.
For more information:
http://www.ahrq.gov/clinic/epc/jhopkepc.htm
http://www.hopkinsmedicine.org/gim/faculty/Bennett.html
Newer doesn't mean better when it comes to type 2 diabetes drugs
Johns Hopkins researchers examine newest medications, find they come up short
2011-03-15
ELSE PRESS RELEASES FROM THIS DATE:
CDC makes reproductive health surveys available through IHME's new Global Health Data Exchange
2011-03-15
SEATTLE – A wealth of maternal and child health data is being made immediately and freely accessible through a new collaboration between the Institute for Health Metrics and Evaluation (IHME) and the Centers for Disease Control and Prevention's (CDC) Division of Reproductive Health.
The Division chose IHME's Global Health Data Exchange (GHDx) to host its reports and datasets for an extensive series of reproductive health survey data from more than 30 countries that have received technical assistance from the Division from 1975 to the present. The datasets cover a wide ...
Heavy drinking associated with increased risk of death from pancreatic cancer
2011-03-15
CHICAGO – Heavy alcohol consumption, specifically three or more glasses of liquor a day, is associated with an increased risk of death from pancreatic cancer, according to a report in the March 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
"Alcoholic beverage consumption – a modifiable lifestyle factor – is causally related to several cancers, including oral cavity, pharynx, larynx, esophagus, liver, colorectum and female breast," the authors write as background information in the article. "Heavy alcohol consumption causes acute and chronic ...
Stopping smoking shortly before surgery is not associated with increased postoperative complications
2011-03-15
CHICAGO -- A meta-analysis of nine previous studies found that quitting smoking shortly before surgery was not associated with an increased risk of postoperative complications, according to a report published online today that will appear in the July 11 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
"Cigarette smoking has been implicated as a risk factor for postoperative complications across a spectrum of surgical specialties," the authors provide as background information. "Compared with nonsmokers, smokers who undergo surgery have ...
Vitamin D insufficiency high among patients with early Parkinson disease
2011-03-15
CHICAGO – Patients with a recent onset of Parkinson disease have a high prevalence of vitamin D insufficiency, but vitamin D concentrations do not appear to decline during the progression of the disease, according to a report in the March issue of Archives of Neurology, one of the JAMA/Archives journals.
Vitamin D is now considered a hormone that regulates a number of physiological processes. "Vitamin D insufficiency has been associated with a variety of clinical disorders and chronic diseases, including impaired balance, decreased muscle strength, mood and cognitive ...
Omega-3 fatty acid intake linked with reduced risk of age-related macular degeneration in women
2011-03-15
CHICAGO – Regular consumption of fish and omega-3 fatty acids found in fish is associated with a significantly reduced risk of developing age-related macular degeneration in women, according to a report posted online today that will appear in the June issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
"An estimated nine million U.S. adults aged 40 years and older show signs of age-related macular degeneration (AMD)," the authors write as background information in the article. "An additional 7.3 million persons have early age-related macular degeneration, ...
Stroke incidence higher among patients with certain type of retinal vascular disease
2011-03-15
CHICAGO – Patients with a disease known as retinal vein occlusion (RVO) have a significantly higher incidence of stroke when compared with persons who do not have RVO, according to a report in the March issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
"Retinal vein occlusion (RVO) is a retinal vascular disease in which a retinal vein is compressed by an adjacent retinal artery, resulting in blood flow turbulence, thrombus formation, and retinal ischemia," the authors write as background information in the article. "Although RVO is a significant cause ...
Gender stereotypes about math develop as early as second grade
2011-03-15
Children express the stereotype that mathematics is for boys, not for girls, as early as second grade, according to a new study by University of Washington researchers. And the children applied the stereotype to themselves: boys identified themselves with math whereas girls did not.
The "math is for boys" stereotype has been used as part of the explanation for why so few women pursue science, mathematics and engineering careers. The cultural stereotype may nudge girls to think that "math is not for me," which can affect what activities they engage in and their career ...
Monash scientists uncover a new understanding of male puberty
2011-03-15
Scientists from Monash University have uncovered a new understanding of how male puberty begins.
The key to their findings lies with a protein known as SMAD3 and the rate at which it is produced.
Researchers, Associate Professor Kate Loveland and Dr Catherine Itman from the Faculty of Medicine, Nursing and Health Sciences have discovered through laboratory testing that half as much SMAD3 protein results in faster maturation than the norm, and an inability to create SMAD3 results in abnormal responses to testosterone.
"SMAD3 is a protein that translates signals from ...
Research may lead to new and improved vaccines
2011-03-15
Alum is an adjuvant (immune booster) used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine. The new findings will help the medical community produce more effective vaccines and may open the doors for creating new vaccines for diseases such as HIV or tuberculosis.
"Understanding alum properties will help other vaccines because we are one step deeper into the mechanistic insight of adjuvants, ...
Neuro signals study gives new insight into brain disorders
2011-03-15
Research into how the brain transmits messages to other parts of the body could improve understanding of disorders such as epilepsy, dementia, multiple sclerosis and stroke.
Scientists at the University of Edinburgh have identified a protein crucial for maintaining the health and function of the segment of nerve fibres that controls transmission of messages within the brain.
The study, published in the journal Neuron, could help direct research into neurodegenerative disorders, in which electrical impulses from the brain are disrupted. This can lead to inability to ...
LAST 30 PRESS RELEASES:
Mysterious ‘Dark Dwarfs’ may be hiding at the heart of the Milky Way
Real-world data shows teclistamab can benefit many multiple myeloma patients who would have been ineligible for pivotal trial
Scientists reveal how a key inflammatory molecule triggers esophageal muscle contraction
Duration of heat waves accelerating faster than global warming
New mathematical insights into Lagrangian turbulence
Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug
Artificial solar eclipses in space could shed light on Sun
Probing the cosmic Dark Ages from the far side of the Moon
UK hopes to bolster space weather forecasts with Europe's first solar storm monitor
Can one video change a teen's mindset? New study says yes - but there’s a catch
How lakes connect to groundwater critical for resilience to climate change, research finds
Youngest basaltic lunar meteorite fills nearly one billion-year gap in Moon’s volcanic history
Cal Poly Chemistry professor among three U.S. faculty to be honored for contributions to chemistry instruction
Stoichiometric crystal shows promise in quantum memory
Study sheds light on why some prostate tumors are resistant to treatment
Tree pollen reveals 150,000 years of monsoon history—and a warning for Australia’s northern rainfall
Best skin care ingredients revealed in thorough, national review
MicroRNA is awarded an Impact Factor Ranking for 2024
From COVID to cancer, new at-home test spots disease with startling accuracy
Now accepting submissions: Special Collection on Cognitive Aging
Young adult literature is not as young as it used to be
Can ChatGPT actually “see” red? New results of Google-funded study are nuanced
Turning quantum bottlenecks into breakthroughs
Cancer-fighting herpes virus shown to be an effective treatment for some advanced melanoma
Eliminating invasive rats may restore the flow of nutrients across food chain networks in Seychelles
World’s first: Lithuanian scientists’ discovery may transform OLED technology and explosives detection
Rice researchers develop superstrong, eco-friendly materials from bacteria
Itani studying translation potential of secure & efficient software updates in industrial internet of things architectures
Elucidating the source process of the 2021 south sandwich islands tsunami earthquake
Zhu studying use of big data in verification of route choice models
[Press-News.org] Newer doesn't mean better when it comes to type 2 diabetes drugsJohns Hopkins researchers examine newest medications, find they come up short